A recent study, paid for by AbbVie - maker of Synthroid, a brand-name version of levothyroxine - said a medical and pharmacy claims database showed that the prevalence of hypothyroidism ...
NORTH CHICAGO, Ill. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Neomorph, Inc. today announced a collaboration and option-to-license agreement to develop novel molecular ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback